dr. cone on cardiac toxicity with gnrh agonists in prostate cancer
Published 4 years ago • 193 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:18
dr. cone on research investigating cardiac toxicity of gnrh agonists/antagonists in prostate cancer
-
0:57
dr. cone on evaluating the relative risk of gnrh agonists versus antagonists in prostate cancer
-
1:47
adt with gnrh antagonists in prostate cancer
-
3:58
significance of gnrh antagonists in prostate cancer
-
2:00
dr. olsson on differences between lhrh agonists and antagonists in prostate cancer
-
5:38
gnrh antagonists versus gnrh agonists
-
0:46
antibody-drug conjugates in gynecological cancers
-
1:14
prognostic value of beta-2 adrenergic receptor levels in her2 breast cancer
-
1:15
evaluating organ preservation in node-negative low rectal cancer
-
0:45
dr. hahn on patients with prostate cancer whom neither docetaxel or abiraterone is an option
-
1:04
dr. penson on questions regarding next-generation ar inhibitors in prostate cancer
-
1:12
expectations with biopsy
-
1:46
faster prostate cancer treatment pkg
-
1:05
dr. kearns on aes associated with surgery in prostate cancer
-
3:46
ask the expert: do low volume metastatic disease patients benefit from early docetaxal?
-
1:06
what are the current treatment strategies for rectal cancer?
-
1:24
the link between breast cancer and prostate cancer
-
2:40
destiny-gastric02: 2l t-dxd in her2 gastric cancers
-
0:36
what are the current unmet needs in anal cancer?